CCL2 and neoplasm: Using neutralizing antibodies against CCL2 hindered the accumulation of TAMs and potentiated the anti-tumor efficacy of CD8+ T cells in the TME as the Ly6Chi monocytes were sequestered in the BM; thereby, it was shown a reduction in tumor growth and metastasis (146, 239) (Figure 1B).